This brand name is authorized in Japan, Turkey.
The drug CONIEL contains one active pharmaceutical ingredient (API):
1
|
UNII
0A6746FWDL - BENIDIPINE HYDROCHLORIDE
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| C08CA15 | Benidipine | C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| JP | 医薬品医療機器総合機構 | 2171021F1024, 2171021F2020, 2171021F3027 |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699525015983 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.